Contact

+44 (0)3 333 112 131

  • FR
  • EU
  • US
Bluereg
  • Services
    • Development
      • Strategy
        • Drug Development Consulting
        • Advanced Therapies (ATMP)
        • Early Access Programs (ATU)
        • Health Authority
          Scientific Advice
        • CMC Product Development
        • Clinical Trial Applications (CTA)
        • Orphan Drug Designations (ODDs)
        • Paediatric Investigation Plans (PIPs)
        • EMA/HTA Parallel Scientific Advice
      • Scientific Writing
        • Scientific & Dossier Writing
        • CMC Regulatory support
        • Safety reports
        • Clinical study reports
    • Registration
      • Europe and United States
        • Registration Strategy
        • Registration & Regulatory Roadmap
        • Pharmacovigilance
        • European Services
        • United States Services
      • International Registration
        • Export Countries
      • Publishing
      • Scientific and Dossier Writing
        • CTD Dossier Writing
        • CMC Regulatory support
        • Clinical study reports
        • Safety reports
    • Commercialisation
      • Launch Activities
        • Advertising & Promotional Material
        • Pricing & Reimbursement
        • Quality System and Audit
        • Exploitant Services
      • Life Cycle Management
    • Market Specific Services
      • France
        • Registration
        • Life Cycle Management
        • Quality & Audits
        • Product Quality Reviews
        • Promotional materials
        • Market Access France
        • Pharmacovigilance
        • Early Access Programmes (ATU)
      • United Kingdom and Ireland
        • United Kingdom and Ireland
        • Brexit
      • Europe
      • United States
      • Worldwide
    • Outsourcing Programs
      • Program Management
      • Registration &
        Regulatory Roadmap
      • Registration
      • SME representation
      • Publishing & Submissions
      • Promotion & Advertising
      • Export Countries
      • Early Access Programs (ATU)
      • Exploitant Services
  • Resources
    • Documents
    • News
  • Careers
    • Join the family
    • Vacancies
  • About us
    • Who are we
    • Why BlueReg
    • How we help
    • Our Management Team
    • Our Senior Team
    • Social Contribution
    • Affiliations
  • Contact us
    • Send us a message
    • Office locator
  • Services
    • Development
      • Strategy
        • Drug Development Consulting
        • Advanced Therapies (ATMP)
        • Early Access Programs (ATU)
        • Health Authority
          Scientific Advice
        • CMC Product Development
        • Clinical Trial Applications (CTA)
        • Orphan Drug Designations (ODDs)
        • Paediatric Investigation Plans (PIPs)
        • EMA/HTA Parallel Scientific Advice
      • Scientific Writing
        • Scientific & Dossier Writing
        • CMC Regulatory support
        • Safety reports
        • Clinical study reports
    • Registration
      • Europe and United States
        • Registration Strategy
        • Registration & Regulatory Roadmap
        • Pharmacovigilance
        • European Services
        • United States Services
      • International Registration
        • Export Countries
      • Publishing
      • Scientific and Dossier Writing
        • CTD Dossier Writing
        • CMC Regulatory support
        • Clinical study reports
        • Safety reports
    • Commercialisation
      • Launch Activities
        • Advertising & Promotional Material
        • Pricing & Reimbursement
        • Quality System and Audit
        • Exploitant Services
      • Life Cycle Management
    • Market Specific Services
      • France
        • Registration
        • Life Cycle Management
        • Quality & Audits
        • Product Quality Reviews
        • Promotional materials
        • Market Access France
        • Pharmacovigilance
        • Early Access Programmes (ATU)
      • United Kingdom and Ireland
        • United Kingdom and Ireland
        • Brexit
      • Europe
      • United States
      • Worldwide
    • Outsourcing Programs
      • Program Management
      • Registration &
        Regulatory Roadmap
      • Registration
      • SME representation
      • Publishing & Submissions
      • Promotion & Advertising
      • Export Countries
      • Early Access Programs (ATU)
      • Exploitant Services
  • Resources
    • Documents
    • News
  • Careers
    • Join the family
    • Vacancies
  • About us
    • Who are we
    • Why BlueReg
    • How we help
    • Our Management Team
    • Our Senior Team
    • Social Contribution
    • Affiliations
  • Contact us
    • Send us a message
    • Office locator
BlueReg Group EDQM
Categories
  • All

  • Events

  • Group

  • Industry Recognition

  • News

  • On parle de nous

Contact our experts today

Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any area of product development, commercialisation and early access programs, and life cycle management

Make an enquiry

About us

Welcome to BlueReg, an international consulting company for the pharmaceutical industry, specializing in development, regulatory affairs, economic affairs, quality and pharmacovigilance. We have built long-term partnerships with many clients by offering them “tailor-made” services guaranteeing expert advice and efficient solutions, thus supporting their projects towards success.

Our links

  • Affiliations
  • Careers
  • Terms of use
  • Privacy Policy
  • GDPR

Get in touch with us here:

  • contact@blue-reg.com
Manage Cookies

Discover our
last white Paper

Download